Comparison of Efficacy of Beractant and Poractant Treatment Performed with Minimal Invasive Technique

Document Type : Original Article


1 Department of Neonatology, Faculty of Medicine, Adiyaman University, Adiyaman, Turkey

2 Department of Neonatology, Zeynep Kamil Maternity and Children’s Diseases Training and Research Hospital, Istanbul, Turkey


Background: The literature review has demonstrated the short-term benefits of minimally invasive surfactant therapy (MIST) in spontaneously breathing preterm neonates. This study was conducted to compare the efficacy of beractant and poractant alfa treatments performed with the MIST method in newborns with respiratory distress syndrome (RDS) and its effect on preterm morbidity and mortality.
Methods: The patients diagnosed with RDS less than 35 weeks of gestational age and stabilized with nasal continuous positive airway pressure (nCPAP) in the delivery room were screened retrospectively. The cases were divided into two groups of beractant (BG) and poractant alfa (PG). While the BG (n=24) consisted of patients receiving beractant treatment with MIST during nCPAP, the PG (n=34) were those subjected to poractant alfa treatment.
Results: It was found out that in PG the scores of surfactant reflux to esophagus and desaturation during surfactant administration were significantly lower (P=0.012 and P=0.009, respectively). No significant difference was observed between the two groups regarding bronchopulmonary dysplasia, sepsis, patent ductus arteriosus, pneumothorax, intubation rate in postnatal 72 h, total period of intubation, nCPAP, duration of hospitalization, and mortality rate.
Conclusion: According to the results of this study, surfactant reflux to esophagus and desaturation during the intervention procedure were lower in the PG group, most probably due to a lower volume of poractant than beractant. However, since a small number of patients were included in this study, it is recommended to perform further studies consisting of a larger number of cases.


  1. Wilinska M, Bachman T, Swietlinski J, Gajewska E, Meller J, Helwich E, et al. Impact of the shift to neonatal noninvasive ventilation in Poland: a population study. Pediatr Crit Care Med. 2014; 15(2):155‐61.
  2. Ramanathan R, Sekar KC, Rasmussen M, Bhatia J, Soll RF. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants
  3. Kattwinkel J, Robinson M, Bloom BT, Delmore
    P, Ferguson JE. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol. 2004; 24(6):360-5.
  4. Kribs A, Pillekamp F, Hünseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely prematüre infants (postmenstrual age ≤27 weeks). Paediatr Anaesth. 2007; 17(4):364-9.
  5. Stevens TP, Sinkin RA. Surfactant replacement therapy. Chest. 2007; 131(5):1577-82.

10. Shah S. Exogenous surfactant: ıntubated present, nebulized future? World J Pediatr. 2011; 7(1):11-5.

11. Kribs A, Härtel C, Kattner E, Vochem M, Küster H, Möller J, et al. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Padiatr. 2010; 222(1):13-7.

12. Mehler K, Grimme J, Abele J, Huenseler C, Roth B, Kribs A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr. 2012; 101(12):

13. Dargaville PA, Aiyappan A, De Paoli AG, Kuschel CA, Kamlin CO, Carlin JB, et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed. 2013; 98(2):F122-6. 

14.Dargaville PA. Innovation in surfactant therapy I:surfactant lavage and surfactant administration by fluid bolus using minimally invasivete chniques.Neonatology.2012;101(4):326-36.
15. Mazela J, Merritt TA, Finer NN. Aerosolized surfactants. Curr Opin Pediatr. 2007; 19(2):155-62.
16. Roberts KD, Lampland AL, Meyers PA, Worwa CT,Plumm BJ, Mammel MC. Laryngeal mask airway for surfactant administration in a newborn animal model. Pediatr Res. 2010; 68(5):414-8.
17. More K, Sakhuja P, Shah PS. Minimally invasive surfactant administration in preterm infants: a meta-narrative review. JAMA Pediatr. 2014;168(10):901-8.
18. Fischer HS, Buhrer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia:a meta-analysis. Pediatrics. 2013; 132(5):e1351-60.
19. Mohammadizadeh M, Ardestani AG, Sadeghnia AR.Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and
outcome. J Res Pharm Pract. 2015; 4(1):31-6.
20. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfaktan administiration via thin catheter during spontaneous breathing: randomized controlled trial.Pediatrics. 2013; 131(2):e502-9.
21. Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C,et al. German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet.2011; 378(9803):1627-34.
22. Bao Y, Zhang G, Wu M, Ma L, Zhu J. A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center. BMC Pediatr. 2015; 15:21.
23. Klebermass-Schrehof K, Wald M, Schwindt J, Grill A,Prusa AR, Haiden N, et al. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology. 2013;103(4):252-8.
24. Tomar RS, Ghuliani R, Yadav D. Effect of surfactanttherapy using orogastric tube for tracheal catheterization in preterm newborns with respiratory distress. Indian J Pediatr. 2017;84(4):257-61.